Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus

Accumulating evidence has supported an increased risk of osteoporotic fracture in postmenopausal women and elderly men diagnosed with diabetes mellitus. However, it is not uncommon for young and middle-aged male patients diagnosed with type 2 diabetes mellitus (T2DM) to suffer from osteopenia or ost...

Full description

Saved in:
Bibliographic Details
Main Authors: X. X. Liu, L. Jiang, Q. Liu, J. Zhang, W. Niu, J. Liu, Q. Zhang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/6191468
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166924759007232
author X. X. Liu
L. Jiang
Q. Liu
J. Zhang
W. Niu
J. Liu
Q. Zhang
author_facet X. X. Liu
L. Jiang
Q. Liu
J. Zhang
W. Niu
J. Liu
Q. Zhang
author_sort X. X. Liu
collection DOAJ
description Accumulating evidence has supported an increased risk of osteoporotic fracture in postmenopausal women and elderly men diagnosed with diabetes mellitus. However, it is not uncommon for young and middle-aged male patients diagnosed with type 2 diabetes mellitus (T2DM) to suffer from osteopenia or osteoporosis. Few studies focused on this population group are available. The aim of this study is to evaluate bone metabolic status and investigate the influence of T2DM on bone metabolism in 30-50-year-old men. Anthropometric assessment and blood samples were obtained from 160 patients with T2DM and 69 nondiabetic volunteers. Serum parathyroid hormone (PTH) and bone turnover markers (BTMs), including serum procollagen type I N-terminal peptide (PINP), osteocalcin (OC), and β-cross-linked C-telopeptide of type I collagen (β-CTX), were analysed. No significant differences were observed based on age, body mass index, systolic blood pressure, serum calcium, phosphorus, creatinine, total protein, and albumin levels when comparing T2DM and control groups. Fasting blood glucose, HbA1c, triglyceride (TG), total cholesterol, and low-density lipoprotein cholesterol were significantly increased, while high-density lipoprotein cholesterol was significantly decreased in the T2DM group. Compared with controls, diabetic patients showed lower serum PINP, OC, and PTH levels, whereas serum β-CTX levels were similar between the two groups. Moreover, HbA1c levels were positively correlated with PINP and inversely associated with PTH levels. TG levels were negatively correlated with OC or β-CTX levels. Furthermore, multiple linear regression revealed a positive correlation between HbA1c and PINP levels. These results also revealed a negative association between HbA1c and PTH, and between TG and OC levels, even after adjusting for expected confounder factors. Collectively, these findings indicated that young and middle-aged male patients with T2DM showed a lower turnover state resulting from bone formation inhibition. Glucose and lipid metabolic disorders may affect bone formation through different pathways.
format Article
id doaj-art-e58b81a9d6654a85979688d4e8675e3e
institution OA Journals
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-e58b81a9d6654a85979688d4e8675e3e2025-08-20T02:21:19ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/61914686191468Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes MellitusX. X. Liu0L. Jiang1Q. Liu2J. Zhang3W. Niu4J. Liu5Q. Zhang6NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaNHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, ChinaAccumulating evidence has supported an increased risk of osteoporotic fracture in postmenopausal women and elderly men diagnosed with diabetes mellitus. However, it is not uncommon for young and middle-aged male patients diagnosed with type 2 diabetes mellitus (T2DM) to suffer from osteopenia or osteoporosis. Few studies focused on this population group are available. The aim of this study is to evaluate bone metabolic status and investigate the influence of T2DM on bone metabolism in 30-50-year-old men. Anthropometric assessment and blood samples were obtained from 160 patients with T2DM and 69 nondiabetic volunteers. Serum parathyroid hormone (PTH) and bone turnover markers (BTMs), including serum procollagen type I N-terminal peptide (PINP), osteocalcin (OC), and β-cross-linked C-telopeptide of type I collagen (β-CTX), were analysed. No significant differences were observed based on age, body mass index, systolic blood pressure, serum calcium, phosphorus, creatinine, total protein, and albumin levels when comparing T2DM and control groups. Fasting blood glucose, HbA1c, triglyceride (TG), total cholesterol, and low-density lipoprotein cholesterol were significantly increased, while high-density lipoprotein cholesterol was significantly decreased in the T2DM group. Compared with controls, diabetic patients showed lower serum PINP, OC, and PTH levels, whereas serum β-CTX levels were similar between the two groups. Moreover, HbA1c levels were positively correlated with PINP and inversely associated with PTH levels. TG levels were negatively correlated with OC or β-CTX levels. Furthermore, multiple linear regression revealed a positive correlation between HbA1c and PINP levels. These results also revealed a negative association between HbA1c and PTH, and between TG and OC levels, even after adjusting for expected confounder factors. Collectively, these findings indicated that young and middle-aged male patients with T2DM showed a lower turnover state resulting from bone formation inhibition. Glucose and lipid metabolic disorders may affect bone formation through different pathways.http://dx.doi.org/10.1155/2020/6191468
spellingShingle X. X. Liu
L. Jiang
Q. Liu
J. Zhang
W. Niu
J. Liu
Q. Zhang
Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
Journal of Diabetes Research
title Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
title_full Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
title_fullStr Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
title_short Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
title_sort low bone turnover markers in young and middle aged male patients with type 2 diabetes mellitus
url http://dx.doi.org/10.1155/2020/6191468
work_keys_str_mv AT xxliu lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT ljiang lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT qliu lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT jzhang lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT wniu lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT jliu lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus
AT qzhang lowboneturnovermarkersinyoungandmiddleagedmalepatientswithtype2diabetesmellitus